EpiPen competitor alternative Auvi-Q returning soon


(CNN) Pharmaceutical business Kaleo stated Wednesday that it will reestablish its compact epinephrine autoinjector to the United States market in the very first half of 2017. Auvi-Q can be utilized to deal with dangerous allergies, consisting of anaphylaxis, by providing epinephrine to assist unwind muscles, open respiratory tracts and decrease swelling set off when the body has an allergy.

Despite high client expect a less-expensive option to the EpiPen epinephrine autoinjector, the Virginia-based business might come across some resistance in its go back to the marketplace.